Apparent increase in type I 5′-deiodinase activity induced by antiepileptic medication in mentally retarded subjects

Hormone Research

Volumn 58, Issue 6, 2002, Pages 273-278

  Premachandra, B N ^a,b   Radparvar, A ^c   Burman, K ^d   Williams, I K ^a  

^a Thyroid Specialty Laboratory   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c Missouri Endocr and Diabetes Ctr   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Carbamazepine; Mental retardation; Phenytoin; Reverse T3; Thyroid hormones

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; IODIDE PEROXIDASE; LIOTHYRONINE; PHENYTOIN; THYROID HORMONE; THYROTROPIN; THYROXINE; THYROXINE BINDING GLOBULIN; THYROXINE DEIODINASE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DEIODINATION; DRUG EFFECT; DRUG RESPONSE; ENZYME ACTIVITY; EUTHYROIDISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HORMONE DETERMINATION; HUMAN; LABORATORY TEST; LIOTHYRONINE BLOOD LEVEL; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; FEMALE; HORMONES; HUMANS; IODIDE PEROXIDASE; MALE; MENTAL RETARDATION; PHENYTOIN; SEIZURES; THYROID FUNCTION TESTS; THYROID HORMONES; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; TRIIODOTHYRONINE, REVERSE;

EID: 0242684744     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066444     Document Type: Article

References (37)

1. Grossman HJ (ed): Classification in Mental Retardation. Washington, American Association on Mental Deficiency, 1983.
2. Eayrs JT: Influence of the thyroid on the central nervous system. Br Med Bull 1960;16:122-127.
3. Paschkis KE, Rakoff AE, Cantarow A, Rupp JJ: Clinical Endocrinology, Ed 3. New York, Harper & Row, 1967.
4. Haddow JE, Palomsaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermes RJ, Waisbren SE, Faix JD, Klein RZ: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-555.
5. Dussault JH: An update on screening for congenital hypothyroidism. Thyroid Today 1985; VIII.
6. Klein RZ, Mitchell ML: Hypothyroidism in infants and children; in Braverman LE, Utiger RD (eds): Werner's and Ingbar's The Thyroid, Ed 8. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 973-988.
7. Baldessarini RJ: Drugs and the treatment of psychiatric disorders; in Gilman AG, Goodman LS, Rall TW (eds): The Pharmacological Basis of Therapeutics. New York, MacMillan Publishing, 1985, pp 387-445.
8. Premachandra BN, Wortsman J, Williams IK: Inhibition of serum protein binding of thyroxine in a hypothyroid patient with familial dysalbuminemic hyperthyroxinemia. Clin Biochem 1996;29:85-88.
9. Refetoff S, Fang VS, Marshall JS, Robin NI: Metabolism of thyroxine-binding globulin in man: Abnormal rate of synthesis in inherited TBG deficiency and excess. J Clin Invest 1976;57:485-496.
10. Isojarvi JIT, Pakarinen AJ, Myllyla VV: Thyroid function with antiepileptic drugs. Epilepsia 1992;33:142-148.
11. Utiger RD: Tests of the hypothalamic-pituitary-thyroid axis; in Werner SC, Ingbar SH (eds): The Thyroid, Ed 4. New York, Harper & Row, 1978, pp 367-374.
12. Horimoto M, Nishikawa M, Ishihara T, Yoshi-kawa N, Yoshimura M, Inada M: Bioactivity of thyrotropin (TSH) in patients with central hypothyroidism: Comparison between in vivo 3,5,3′-triiodothyronine response to TSH and in vitro bioactivity of TSH. J Clin Endocrinol Metab 1995;80:1124-1128.
13. Oppenheimer JH, Fisher LV, Nelsoro KM, Jailer JW: Depression of the serum protein-bound iodine level by diphenylhydantoin. J Clin Endocrinol Metab 1961;2:252-262.
14. 3 in diphenylhydantoin-treated patients. Metabolism 1979;28:1161-1165.
15. Liewendahl K, Majuri H, Helenius T: Thyroid function tests in patients on long-term treatment with various anticonvulsant drugs. Clin Endocrinol 1978;8:185-191.
16. Stjernholm MR, Alsever RN, Rudolph MC: Thyroid function tests in diphenylhydantoin-treated patients. Clin Chem 1975;21:1388-1392.
17. Rootwelt K, Ganes T, Johannessen SI: Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scand J Clin Lab Invest 1978;38:731-736.
18. Curran PG, DeGroot LJ: The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocr Rev 1991;12:135-150.
19. Bentsen KD, Gram L, Veje A: Serum thyroid hormones and blood folic acid during mono-therapy with carbamazepine or valproate. Acta Neurol Scand 1983;67:235-241.
20. Surks MI, DeFesi CR: Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. JAMA 1996;275:1495-1498.
21. Liewendahl K, Tikanoja S, Helenius T, Majuri H: Free thyroxine and free triiodothyronine as measured by equilibrium dialysis and analog radioimmunoassay in serum of patients taking phenytoin and carbamazepine. Clin Chem 1985;31:1993-1996.
22. Chin W, Schussler GC: Decreased serum free thyroxine concentration in patients treated with diphenylhydantoin. J Clin Endocrinol 1968;28:181-186.
23. Larsen PR, Atkinson AJ Jr, Wellman HN, Goldsmith RE: The effect of diphenylhydantoin on thyroxine metabolism in man. J Clin Invest 1970;49:1266-1279.
24. Yeo PPB, Bates D, Howe JG, Ratcliffe WA, Schradt CW, Heath A, Evered DC: Anticonvulsants and thyroid function. Br Med J 1978;i:1581-1583.
25. Liewendahl K, Helenius T, Majure H, Ebeling P, Ahlfors UG: Effect of anticonvulsant and antidepressant drugs on iodothyronines in serum. Scand J Clin Lab Invest 1980;40:767-774.
26. Leonard JL, Visser TJ: Biochemistry of deiodination; in Hennemann G (ed): Thyroid Hormone Metabolism. New York, Dekker, 1986, pp 1-189.
27. Toyoda N, Kaptein E, Berry MJ, Harney JW, Larsen PR, Visser TJ: Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases. Endocrinology 1997;138:213-219.
28. Burman KD, Smallridge RC, Burge JR, Carlson D, Wartofsky L: Ipodate restores the fasting-induced decrement in thyrotropin secretion. J Clin Endocrinol Metab 1983;57:597-602.
29. Leonard JL, Silva JE, Kaplan MM, Mellen SA, Visser TJ, Larsen PR: Acute posttranscriptional regulation of cerebrocortical and pituitary iodothyronine 5′-deiodinases by thyroid hormone. Endocrinology 1984;114:998-1004.
30. Oppenheimer JH, Schwartz HL, Strait KA: The molecular basis of thyroid hormone actions; in Braverman LE, Utiger RD (eds): Werner's and Ingbar's The Thyroid, Ed 7. Philadelphia, Lippincott-Raven, 1996, pp 162-184.
31. Leonard JL, Koehrle J: Intracellular pathways of iodothyronine metabolism; in Braverman LE, Utiger RD (eds): Werner's and Ingbar's The Thyroid, Ed 8. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 136-173.
32. Eravci M, Pinna G, Meinhold H, Baumgartner A: Effects of pharmacological and nonpharmacological treatments on thyroid hormone metabolism and concentrations in rat brain. Endocrinology 2000;141:1027-1040.
33. Baumgartner A, Campos-Barros A, Gaio U, Hessenius C, Flechner A, Meinhold H: Carbamazepine affects triiodothyronine production and metabolization in rat hippocampus. Life Sci 1994;54:PL401-PL407.
34. 3 (abstract). Isr J Med Sci 1972;8:1868.
35. 131 I in the rat. Endocrinology 1996;79:106-108.
36. Wartofsky L, Burman KD: Alterations in thyroid function in patients with systemic illnesses: The 'euthyroid sick syndrome'. Endocr Rev 1982;3:164-217.
37. Docter R, Krenning EP, de Jong M, Hennemann G: The sick euthyroid syndrome: Changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 1993;39:499-518.